MOH vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 04, 2026

MOH

47.3
AI Score
VS
CLOV Wins

CLOV

53.3
AI Score

Investment Advisor Scores

MOH

47score
Recommendation
HOLD

CLOV

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MOH CLOV Winner
Forward P/E 18.9036 37.7358 MOH
PEG Ratio 0.887 0 Tie
Revenue Growth -5.7% 55.6% CLOV
Earnings Growth -75.3% 0.0% CLOV
Tradestie Score 47.3/100 53.3/100 CLOV
Profit Margin -0.0% -0.7% MOH
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

MOH 1M: -6.5% · 3M: -16.8% CLOV 1M: +1.9% · 3M: -13.4%

Current Technical Phase

MOH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.1%), weak momentum, RSI 44

RSI (14): 43.9 · Price: $189.54

CLOV

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -3.2%) with fading momentum, RSI 48

RSI (14): 47.6 · Price: $4.38

Fundamentals Snapshot

Metric MOH CLOV
Market Cap — —
Forward P/E 22.2 29.2
Trailing P/E 1291.8 —
Revenue (TTM) — —
Revenue Growth -0.1% 0.6%
Gross Margin 0.1% 0.2%
Operating Margin 0.0% 0.0%
EPS 0.14 -0.05
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLOV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.